MIRA insider transaction filings
MIRA PHARMACEUTICALS, INC. — 27 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-15. Screen MIRA transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for MIRA between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — MIRA PHARMACEUTICALS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-15 | 4 | Whalen Matthew Pratt — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Shekhat Denil Nanji — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | MacPherson Edward Clouston — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Del Giudice Matthew Paul — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Aminov Erez — Chief Executive Officer, Director | Grant/award (A): 83,500 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | Shekhat Denil Nanji — Director | Grant/award (A): 22,378 @ $1.35 | EDGAR |
| 2025-10-03 | 4 | Aminov Erez — Chief Executive Officer, Director | Grant/award (A): 2,685,456 | EDGAR |
| 2025-09-18 | 4 | Aminov Erez — Chief Executive Officer, Director | Grant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | Aminov Erez — Chief Executive Officer, Director | Grant/award (A): 62,500 @ $1.37 | EDGAR |
| 2024-12-10 | 4 | Aminov Erez — Chief Executive Officer, Director | Grant/award (A): 2,000,000 (derivative) @ $0 · Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2024-12-10 | 4 | Yanez Michelle — Chief Financial Officer | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-12-10 | 4 | Whalen Matthew Pratt — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-12-10 | 4 | Shekhat Denil Nanji — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-12-10 | 4 | MacPherson Edward Clouston — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-12-10 | 4 | Del Giudice Matthew Paul — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-11-27 | 4 | Aminov Erez — Chief Executive Officer, Director | Sale (S): 55,410 @ $1.39 · Sale (S): 44,590 @ $1.27 | EDGAR |
| 2024-08-30 | 4 | McNulty Brian Patrick — 10% owner Bay Shore Trust — 10% owner | Sale (S): 200,000 @ $1.96 | EDGAR |
| 2024-06-21 | 4 | Shekhat Denil Nanji — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Aminov Erez — Chief Executive Officer, Director | Grant/award (A): 379,000 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | Aminov Erez — Chief Executive Officer, Director | Purchase (P): 2,000 @ $1 · Purchase (P): 1,000 @ $1.03 · Purchase (P): 500 @ $1.02 · Purchase (P): 2,000 @ $0.84 · Purchase (P): 1,000 @ $0.85 · Purchase (P): 600 @ $0.87 · +2 more | EDGAR |
| 2024-03-27 | 4 | Yanez Michelle — Chief Financial Officer | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-03-27 | 4 | Aminov Erez — Chief Executive Officer, Director | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2024-03-27 | 4 | Shekhat Denil Nanji — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-03-27 | 4 | Jerman Michael Allen — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-03-27 | 4 | Del Giudice Matthew Paul — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-03-27 | 4 | MacPherson Edward Clouston — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-12-27 | 4 | McNulty Brian Patrick — 10% owner Bay Shore Trust — 10% owner | Sale (S): 13,367 @ $5.07 · Sale (S): 2,500 @ $5 · Sale (S): 3,213 @ $4.00 · Sale (S): 121 @ $4 · Sale (S): 3,699 @ $3.98 · Sale (S): 2,421 @ $3.77 · +16 more | EDGAR |
Recent 8-K events — MIRA PHARMACEUTICALS, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-17 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-16 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-01 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-31 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-07-10 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-06 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-25 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=MIRA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →